Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonization factor antigen I (CFA/I) and the coli surface (CS) antigens CS1, CS2, CS3, CS4, CS5, and CS6 are the primary fimbrial and fibrillar adhesins expressed by enterotoxigenic Escherichia coli (ETEC). These surface structures are essential for the pathogenesis of ETEC-mediated diarrhea, as they facilitate the attachment of the bacteria to specific receptors on the human small intestinal epithelium, such as asialo-GM1 and Lewis A glycans. CFA/I, CS1, CS2, and CS4 are members of the class 5 fimbriae family, which are assembled via the chaperone-usher pathway and utilize a minor tip-localized protein to mediate high-affinity binding to host cells. While these four are structurally related, CS3, CS5, and CS6 belong to distinct morphological groups, yet all seven are collectively targeted in vaccine formulations due to their high prevalence in clinical cases. Current therapeutic strategies, including multivalent subunit vaccines like MecVax and whole-cell vaccines like ETVAX, aim to induce neutralizing antibodies that block bacterial adhesion and prevent colonization. By inhibiting this initial step of infection, these interventions provide broad protection against the diverse strains of ETEC that cause significant global morbidity.
Inhibition of bacterial attachment to host intestinal epithelial receptors, thereby preventing colonization.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonization factor antigen I and coli surface antigens 1–6 (CFA/I, CS1–CS6).